Ab­b­Vie bails on So­sei Hep­tares pact for nov­el neu­rol­o­gy can­di­dates in blow to dis­cov­ery out­fit's A-list Rolodex

Japan’s So­sei Hep­tares has built a who’s who list of big-name part­ners look­ing to li­cense the com­pa­nies’ dis­cov­ery-stage G pro­tein-cou­pled re­cep­tors for nov­el neu­rol­o­gy path­ways …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER